| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689346A2 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1497295B1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 08/16/2006 | EP1450832B1 Lactic acid bacteria and their use for treating and preventing cancer |
| 08/16/2006 | EP1432702B1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 08/16/2006 | EP1404678B1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 08/16/2006 | EP1401425B1 Organometallic anti-tumour agent |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1370641B1 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1363892B1 Method for the production of a stable pharmaceutical form of paclitaxel |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1297013B1 Use of taci as an anti-tumor agent |
| 08/16/2006 | EP1296647B1 Polymeric micelle compositions |
| 08/16/2006 | EP1276853B1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1252160B1 Methanocarba cycloalkyl nucleoside analogues |
| 08/16/2006 | EP1227810B8 Treating cancer by increasing intracellular malonyl coa levels |
| 08/16/2006 | EP1198233B1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 08/16/2006 | EP1186301B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1115876B1 Receptor based antagonists and methods of making and using |
| 08/16/2006 | EP1107958B1 Pyrimidine compounds |
| 08/16/2006 | EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/16/2006 | EP0972037B1 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 08/16/2006 | EP0888326B1 Novel ortho-naphthoquinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth |
| 08/16/2006 | EP0809655B1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820012A Organosilicon compounds and their use |
| 08/16/2006 | CN1820009A Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors |
| 08/16/2006 | CN1819996A Naphthylene derivatives as cytochrome P450 inhibitors |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819836A Chinese medicinal preparation for treating lung cancer and production thereof |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1819831A Cancer combination therapy comprising AZD217 and ZD1839 |
| 08/16/2006 | CN1819830A Combination therapy |
| 08/16/2006 | CN1819825A Amino acid iodine composition, its production and use thereof |
| 08/16/2006 | CN1819776A Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/16/2006 | CN1818058A In vitro cell culturing method |
| 08/16/2006 | CN1817906A Antibody against human parathormone related peptides |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/16/2006 | CN1817880A 2-bit-substituted quinolone compound and use in pharmacey |
| 08/16/2006 | CN1817866A Group of geldanamycin derivative with nucleoside base |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1817364A Medicine for cancer treatment |
| 08/16/2006 | CN1269958C Zinc finger binding domains for GNN |
| 08/16/2006 | CN1269839C Treatment with anti-ErbB2 antibodies |
| 08/16/2006 | CN1269837C Serial synthetic antibacterial peptide |
| 08/16/2006 | CN1269835C Method for preparing low-polarity ginseng saponin and its aglycone by catalytic pyrolysis |
| 08/16/2006 | CN1269821C Polymorphs of an epothilone analog |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269819C Synthesis of temozolomide and analogs |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269799C Novel retinoid derivatives and production method thereof and anti-cancer pharmaceutical composition comprising same |
| 08/16/2006 | CN1269527C Compound alliin powder injection |
| 08/16/2006 | CN1269522C Traditional Chinese medicine for treating cancer and its preparation method |
| 08/16/2006 | CN1269521C Compound medicine for treating cancer and preparing process thereof |
| 08/16/2006 | CN1269488C Pharmaceutical composition capable of resisting cancer and easing pain |
| 08/16/2006 | CN1269487C Arsenic trioxide oral liquid and its preparation process |
| 08/16/2006 | CN1269486C Medicine composition with synergistic function for treating chronic granulocytic leukemia |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091351 Vanadium compounds for treating cancer |
| 08/15/2006 | US7091346 Purine derivatives and processes for their preparation |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091336 Lentinan is dissolved in alkali solution, then acid solution is added to neutralize the pH, mixing with lyophilized excipient, filtered to eliminate bacteria, subpackaged into an ampoule or bottle, sealed after lyophilization and dried to obtain the final product |
| 08/15/2006 | US7091333 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases |
| 08/15/2006 | US7091323 Human TIMP-1 antibodies |
| 08/15/2006 | US7091310 Chemokine analogs for the treatment of human disease |
| 08/15/2006 | US7091248 Treatment of adrenocortical hypersecretion and tumor growth |
| 08/15/2006 | US7091239 DNA polymerase inhibitors, mikanolide and dihydromikanolide |
| 08/15/2006 | US7091234 Thio-oxindole derivatives |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091229 1,1-Dioxo-2H-naphtho(1,8-cd)isothiazole or 2-oxo-2H-benzo(cd)indole derivatives as anticarcinogenic or antiproliferative agents |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091226 Cancer treatment with epothilones |
| 08/15/2006 | US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091214 Immonomoderators; viricides; anticancer agents |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091205 Use of tetramethylpyrazine in the treatment of brain tumor |
| 08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
| 08/15/2006 | US7091189 Medicament for treating lung cancer |
| 08/15/2006 | US7091188 Stabilization of amrubicin hydrochloride |
| 08/15/2006 | US7091047 Methods and kits for diagnosing tumorigenicity |
| 08/15/2006 | US7091040 P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT) |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/15/2006 | US7090846 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |